Detalhe da pesquisa
1.
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
Proc Natl Acad Sci U S A
; 116(9): 3604-3613, 2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733286
2.
Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination.
Mol Cell Proteomics
; 16(6): 1151-1161, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28348172
3.
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone.
Nucleic Acids Res
; 45(22): 12681-12699, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036586
4.
Examination of HER3 targeting in cancer using monoclonal antibodies.
Proc Natl Acad Sci U S A
; 112(3): 839-44, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564668
5.
Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.
J Pathol
; 239(3): 262-73, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037906
6.
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.
Proc Natl Acad Sci U S A
; 110(5): 1815-20, 2013 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23319610
7.
A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.
Nat Cell Biol
; 9(8): 961-9, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17643115
8.
Computational optimization of antibody humanness and stability by systematic energy-based ranking.
Nat Biomed Eng
; 8(1): 30-44, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550425
9.
Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response.
Sci Immunol
; 9(91): eabq6930, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215193
10.
Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands.
Proc Natl Acad Sci U S A
; 107(28): 12559-63, 2010 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20616021
11.
Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
Mol Oncol
; 17(11): 2415-2431, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341059
12.
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.
Cell Rep Med
; 4(8): 101142, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37557179
13.
Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.
Front Oncol
; 12: 951267, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408164
14.
Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.
Cell Rep
; 38(8): 110418, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196484
15.
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.
Cancer Discov
; 12(11): 2666-2683, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895872
16.
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors.
Cancer Res
; 81(14): 3862-3875, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941614
17.
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.
EMBO Mol Med
; 13(4): e13144, 2021 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660397
18.
Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.
Oncogene
; 40(21): 3665-3679, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941851
19.
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR.
Cell Rep
; 35(8): 109181, 2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34038737
20.
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor.
Cancers (Basel)
; 12(9)2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847130